Navamedic ASA launches SmectaGO[®] – an innovative on-the-go product for treatment of diarrhea

Published: 16.02.2022

Navamedic ASA: Invitation to 2021 Fourth quarter presentation

Published: 14.02.2022

Navamedic ASA: Trading Update

Published: 23.12.2021

Navamedic ASA has entered into a market making agreement with Norne Securities AS

Published: 11.11.2021

Navamedic ASA: Q3 2021 financial results

Published: 04.11.2021

Navamedic ASA: Invitation to 2021 Third quarter presentation

Published: 28.10.2021